NEW YORK (GenomeWeb) – Wafergen Biosystems today priced a public offering of its securities that is expected to bring in $15 million in gross proceeds.

As part of the offering, Wafergen intends to issue 3.9 million shares of common stock, shares of preferred stock convertible into 11.1 million shares of common stock, and warrants to purchase 15 million shares of common stock.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.